Recombinant Bovine Mitochondrial 2-oxoglutarate/malate carrier protein (SLC25A11)

What is the basic function of SLC25A11 in cellular metabolism?

SLC25A11, also known as the mitochondrial 2-oxoglutarate/malate carrier protein or OGCP, catalyzes the transport of 2-oxoglutarate across the inner mitochondrial membrane in an electroneutral exchange for malate or other dicarboxylic acids. This transport function is essential for several key metabolic processes, including:

• The malate-aspartate shuttle (facilitating NADH transport from cytosol to mitochondria)

• The oxoglutarate/isocitrate shuttle

• Gluconeogenesis from lactate

• Nitrogen metabolism

The protein plays a critical role in cellular energy production by facilitating the movement of reducing equivalents between cellular compartments, which is essential for ATP synthesis through oxidative phosphorylation .

What is the structure and sequence length of the bovine SLC25A11 protein?

The bovine 2-oxoglutarate/malate carrier protein sequence has been deduced from overlapping cDNA clones. The protein sequence, including the initiator methionine, is 314 amino acids long. The mature protein has a modified alpha-amino group, although the precise nature of this modification and the exact position of the mature N-terminal amino acid have not been definitively established, though it likely lies within amino acids 1-4 of the deduced protein sequence .

Structural analysis indicates that SLC25A11, like other mitochondrial carrier proteins, contains a characteristic three-fold repeated sequence of approximately 100 amino acids in length. The distribution of hydrophobic amino acids suggests that these domains fold into similar structural motifs, possibly consisting of two transmembrane alpha-helices connected by an extensive extramembranous hydrophilic region .

How is SLC25A11 related to other mitochondrial carrier proteins?

Comparative sequence analysis reveals that SLC25A11 shares structural similarities with other mitochondrial carrier proteins, including:

• ADP/ATP translocase

• The phosphate carrier

• The uncoupling protein from brown fat

All four proteins contain a three-fold repeated sequence of about 100 amino acids, and all these repeats are interrelated. This structural similarity suggests that members of this carrier protein family share similar mechanisms and have evolved from a common ancestral origin .

The common structural motifs across the mitochondrial carrier family indicate a conserved functional mechanism for metabolite transport across the inner mitochondrial membrane, despite the different substrates handled by individual family members .

What are the optimal methods for studying SLC25A11 expression and function?

Several methodological approaches can be employed to study SLC25A11 expression and function:

Protein Expression Analysis:

• Western blotting with specific SLC25A11 antibodies

• Immunofluorescence for cellular localization

• qRT-PCR for mRNA expression analysis

Functional Analysis:

• Transport assays using reconstituted proteoliposomes

• Mitochondrial isolation and respirometry

• Metabolite analysis using mass spectrometry or NMR

For mitochondrial isolation specifically:

• Harvest cells (approximately 2×10^7 cells)

• Lyse cells in Mitochondria Isolation Reagent A

• Add Reagent B and vortex at maximum speed for 5 seconds

• Incubate on ice for 5 minutes, vortexing at maximum speed every minute

• Add 800 μL of Mitochondria Isolation Reagent C and mix by inversion

• Centrifuge at 700 × g for 10 minutes at 4°C

• Collect supernatant and centrifuge at 12,000 × g for 15 minutes at 4°C

• Wash the mitochondrial pellet and centrifuge again at 12,000 × g for 15 minutes at 4°C

• Collect the pellet as the mitochondrial fraction

This protocol allows for the separation of mitochondrial and cytosolic fractions, enabling the study of SLC25A11 localization and function in specific cellular compartments.

What experimental approaches are used to knock down or knock out SLC25A11 in research models?

Several approaches have been documented for manipulating SLC25A11 expression:

siRNA-mediated knockdown:

• Transient knockdown using specific siRNA sequences targeting SLC25A11

• Typically achieves 50-100% reduction in colony formation in cancer cell lines

shRNA-mediated knockdown:

• More stable, long-term knockdown using shRNA constructs

• Similar efficacy to siRNA in reducing colony formation

CRISPR-Cas9 knockout:
For generating SLC25A11 knockout mouse models:

• Prepare a mixture of Cas9 protein (100 ng/μl) and guide RNA (50 ng/μl)

• Inject the mixture into the cytoplasm of pronuclei

• Use specific sgRNA sequences (e.g., 5'-ACTGCATCCGGTTCTTCACC-3' and 5'-CGGATGCAGTTGAGTGGTGA-3')

• Identify indel mutations in F1 mice after TA cloning and sequencing

Verification methods:

• Western blotting to confirm protein reduction

• qRT-PCR to verify mRNA knockdown

• Functional assays to assess metabolic impact

How can researchers assess the effects of SLC25A11 knockdown on cell viability and metabolism?

Multiple assays can be employed to evaluate the consequences of SLC25A11 manipulation:

Cell Viability and Proliferation:

• Clonogenic assay:

  • Plate 1,000-5,000 cells per well in 6-well plates

  • Allow colony formation for 14 days without changing media

  • Stain colonies with 0.005% crystal violet solution

  • Quantify colony number and size

• Apoptosis detection:

  • Collect cells after SLC25A11 siRNA treatment

  • Wash with cold PBS and resuspend in binding buffer

  • Add Annexin V-FITC and PI

  • Analyze by flow cytometry

Metabolic Assessment:

• ATP measurement assays

• NAD+/NADH ratio determination

• Oxygen consumption rate (OCR) measurements

• Extracellular acidification rate (ECAR) analysis

• Metabolite profiling using mass spectrometry

What is the role of SLC25A11 in cancer metabolism and how can it be exploited therapeutically?

SLC25A11 plays a critical role in cancer cell metabolism, particularly in non-small cell lung cancer (NSCLC) and melanoma. Research findings include:

Cancer-specific metabolic dependency:

• Cancer cells exhibit a higher cytosolic to mitochondrial NADH ratio compared to normal cells

• This is consistent with elevated levels of SLC25A11 in cancer cells

• The mitochondrial electron transport chain remains functionally active in cancer cells

SLC25A11 inhibition effects:

• Blocking malate transport through SLC25A11 knockdown significantly impairs ATP production

• This inhibition selectively affects cancer cell growth with minimal impact on normal cells

• SLC25A11 knockdown reduces colony formation by 50-100% in various cancer cell lines

Mechanism of action:

• Cancer cells critically depend on SLC25A11 for transporting NADH from cytosol to mitochondria in the form of malate

• This transport is essential for ATP production through oxidative phosphorylation

• Blocking SLC25A11 reduces ATP production, thereby inhibiting cancer growth

In vivo validation:

• Heterozygous SLC25A11 knockout mice show suppressed KRAS^LA2 lung tumor formation

• This provides proof-of-concept for targeting SLC25A11 in cancer therapy

How does SLC25A11 function in the malate-aspartate shuttle, and what are the implications for cellular energy production?

The malate-aspartate shuttle is a crucial mechanism for transferring reducing equivalents (NADH) from the cytosol to mitochondria, and SLC25A11 plays a central role in this process:

Shuttle mechanism:

• Cytosolic NADH reduces oxaloacetate to malate via cytosolic malate dehydrogenase

• Malate enters the mitochondria in exchange for 2-oxoglutarate via SLC25A11

• Inside mitochondria, malate is oxidized back to oxaloacetate, generating mitochondrial NADH

• Oxaloacetate is transaminated to aspartate, which exits the mitochondria

• In the cytosol, aspartate is converted back to oxaloacetate, completing the cycle

Implications for energy production:

• This shuttle effectively transfers reducing equivalents from cytosolic NADH to mitochondrial NADH

• Mitochondrial NADH feeds into the electron transport chain for ATP production

• Cancer cells show heightened dependence on this shuttle for ATP generation compared to normal cells

Metabolic measurements:
Studies examining the cytosolic to mitochondrial NADH ratio in cancer versus normal cells reveal significant differences:

These findings suggest that cancer cells have adapted to utilize the malate-aspartate shuttle more extensively for their energy needs, making SLC25A11 a promising target for cancer therapy .

What experimental design considerations are crucial when studying SLC25A11 in different disease models?

When designing experiments to study SLC25A11 in disease models, researchers should consider several critical factors:

Variable definition and control:

• Clearly define independent variables (e.g., SLC25A11 expression levels) and dependent variables (e.g., ATP production, cell growth)

• Control variables should be rigorously maintained across experimental conditions

• Identify potential confounding variables that might influence results

Cell type selection:

• Include both cancer and normal cell lines for comparative studies

• Consider tissue-specific expression patterns of SLC25A11

• Use multiple cell lines representing the same cancer type to account for heterogeneity

In vivo model considerations:

• Consider heterozygous versus homozygous knockout models

• Tissue-specific conditional knockout may be preferable to avoid developmental effects

• Age, sex, and genetic background of animal models must be carefully controlled

Measurement parameters:

• ATP production (primary outcome in many SLC25A11 studies)

• NADH/NAD+ ratios in different cellular compartments

• Oxygen consumption rate

• Cell proliferation and apoptosis markers

• Metabolite profiling

Experimental design types:

• Within-subjects design: Useful for measuring changes in the same cellular population before and after SLC25A11 manipulation

• Between-subjects design: Comparing different cell lines or animal models with varying SLC25A11 expression levels

Controls and validation:

• Include scrambled siRNA controls for knockdown experiments

• Perform rescue experiments by reintroducing wild-type SLC25A11

• Validate findings across multiple experimental approaches and model systems

What are common challenges in recombinant SLC25A11 protein expression and purification?

Researchers working with recombinant SLC25A11 often encounter several challenges:

Protein solubility issues:

• As a multi-pass membrane protein, SLC25A11 can form inclusion bodies during bacterial expression

• Solution: Use mild detergents like DDM or LDAO during extraction and purification

• Alternative: Consider mammalian or insect cell expression systems for better folding

Maintaining native conformation:

• Mitochondrial carrier proteins can lose functional conformation during purification

• Solution: Optimize buffer conditions (pH, salt concentration, glycerol percentage)

• Consider nanodiscs or liposomes for maintaining native-like membrane environment

Functional validation:

• Confirming that purified protein retains transport activity is challenging

• Solution: Develop reconstitution assays in proteoliposomes with appropriate substrates

• Use fluorescent probes or radioisotope-labeled substrates to measure transport activity

Expression optimization strategies:

• Test different fusion tags (His, GST, MBP) for improved solubility and purification

• Optimize induction conditions (temperature, inducer concentration, duration)

• Consider codon optimization for the expression system being used

How can researchers address data inconsistencies when studying SLC25A11 in different experimental systems?

When faced with inconsistent results across different experimental systems:

Methodological standardization:

• Establish detailed protocols for all experimental procedures

• Standardize reagents, antibodies, and cell passage numbers

• Use consistent data analysis methods and statistical approaches

System-specific considerations:

• Cell line authentication to ensure genetic identity

• Account for differences in endogenous SLC25A11 expression levels

• Consider compensatory mechanisms that may activate in certain systems

Troubleshooting steps for inconsistent knockdown effects:

• Verify knockdown efficiency at both protein and mRNA levels

• Examine expression of other mitochondrial carriers that might compensate

• Assess cell-specific metabolic profiles to understand differential dependencies

• Consider the impact of culture conditions on metabolic states

Data reconciliation approaches:

• Meta-analysis of multiple experimental datasets

• Cross-validation using complementary techniques

• Development of mathematical models to explain system-specific differences

What are the emerging research questions regarding SLC25A11's role beyond traditional metabolic pathways?

Several promising research directions are emerging:

Redox regulation:

• SLC25A11 may interact with glutathione transport systems

• Potential role in cellular response to oxidative stress

• Connection to Bcl-2 in coordinating mitochondrial glutathione pool enhancement

Signal transduction:

• Potential involvement in metabolic signaling pathways

• Interactions with other cellular components beyond direct transport function

• Role in sensing and responding to cellular energy status

Developmental biology:

• Function during embryonic development and differentiation

• Tissue-specific roles in specialized metabolic niches

• Potential developmental defects in knockout models

Therapeutic targeting:

• Development of specific inhibitors for cancer therapy

• Structure-based drug design targeting SLC25A11 transport function

• Combination approaches with other metabolic pathway inhibitors

How can advanced techniques like CRISPR screening and metabolomics advance our understanding of SLC25A11 function?

Integration of cutting-edge technologies offers new opportunities:

CRISPR-based approaches:

• Genome-wide synthetic lethality screens to identify genes that, when co-deleted with SLC25A11, cause cell death

• CRISPRi/CRISPRa for reversible modulation of SLC25A11 expression

• Base editing for introducing specific point mutations to study structure-function relationships

Metabolomics integration:

• Untargeted metabolomics to identify novel metabolites affected by SLC25A11 manipulation

• Flux analysis using isotope labeling to track metabolic pathway alterations

• Integration with transcriptomics and proteomics for systems-level understanding

Single-cell technologies:

• Single-cell metabolomics to understand cellular heterogeneity in response to SLC25A11 inhibition

• Spatial transcriptomics to map SLC25A11 expression in tissue microenvironments

• Live-cell imaging with metabolic sensors to track real-time changes

Computational approaches:

• Machine learning for predicting cellular responses to SLC25A11 modulation

• Metabolic modeling to simulate the impact of SLC25A11 inhibition on cellular metabolism

• Network analysis to identify key interaction partners and regulatory mechanisms